Association between serum uric acid and deep venous thrombosis in European populations : A two-sample Mendelian randomization study
Copyright © 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved..
BACKGROUND AND AIM: Previous experimental and observational studies showed that serum uric acid (SUA) was associated with deep venous thrombosis (DVT), but the causal relationship is unclear. This study aimed to explore the potential causal association between SUA and DVT.
METHODS AND RESULTS: We designed a two-sample Mendelian randomization (MR) analysis by using summary-level data from large genome-wide association studies performed in European individuals. A total of 14 SUA-related single-nucleotide polymorphisms (SNPs) (P value < 5 × 10-8) were identified as instrumental variables. The inverse variance weighted method was used as the primary method to compute the odds ratios (ORs) and 95 % confidence intervals (95 % CIs) for per standard deviation increase in SUA. MR Egger, weighted median, weighted mode, and simple mode were also applied to test the robustness of the results. We found no significant causal effects of serum uric acid on deep venous thrombosis (odds ratio [OR]: 1.000, 95 % confidence interval [CI]: 0.998-1.002, p = 0.78) by using inverse variance weighted. MR analyses based on other methods showed similar results.
CONCLUSIONS: There was no potential causal associations between higher genetically predicted SUA levels and increased risk of deep venous thrombosis. Further, MR studies with more valid SNPs and more DVT cases are needed. Validation of the findings is also recommended.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Nutrition, metabolism, and cardiovascular diseases : NMCD - 34(2024), 4 vom: 22. März, Seite 1021-1027 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Liu, Yue [VerfasserIn] |
---|
Links: |
---|
Themen: |
268B43MJ25 |
---|
Anmerkungen: |
Date Completed 18.03.2024 Date Revised 18.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.numecd.2024.01.018 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368919730 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368919730 | ||
003 | DE-627 | ||
005 | 20240318234456.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.numecd.2024.01.018 |2 doi | |
028 | 5 | 2 | |a pubmed24n1334.xml |
035 | |a (DE-627)NLM368919730 | ||
035 | |a (NLM)38402000 | ||
035 | |a (PII)S0939-4753(24)00020-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Liu, Yue |e verfasserin |4 aut | |
245 | 1 | 0 | |a Association between serum uric acid and deep venous thrombosis in European populations |b A two-sample Mendelian randomization study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.03.2024 | ||
500 | |a Date Revised 18.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved. | ||
520 | |a BACKGROUND AND AIM: Previous experimental and observational studies showed that serum uric acid (SUA) was associated with deep venous thrombosis (DVT), but the causal relationship is unclear. This study aimed to explore the potential causal association between SUA and DVT | ||
520 | |a METHODS AND RESULTS: We designed a two-sample Mendelian randomization (MR) analysis by using summary-level data from large genome-wide association studies performed in European individuals. A total of 14 SUA-related single-nucleotide polymorphisms (SNPs) (P value < 5 × 10-8) were identified as instrumental variables. The inverse variance weighted method was used as the primary method to compute the odds ratios (ORs) and 95 % confidence intervals (95 % CIs) for per standard deviation increase in SUA. MR Egger, weighted median, weighted mode, and simple mode were also applied to test the robustness of the results. We found no significant causal effects of serum uric acid on deep venous thrombosis (odds ratio [OR]: 1.000, 95 % confidence interval [CI]: 0.998-1.002, p = 0.78) by using inverse variance weighted. MR analyses based on other methods showed similar results | ||
520 | |a CONCLUSIONS: There was no potential causal associations between higher genetically predicted SUA levels and increased risk of deep venous thrombosis. Further, MR studies with more valid SNPs and more DVT cases are needed. Validation of the findings is also recommended | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Deep venous thrombosis | |
650 | 4 | |a European population | |
650 | 4 | |a Mendelian randomization | |
650 | 4 | |a Serum uric acid | |
650 | 7 | |a Uric Acid |2 NLM | |
650 | 7 | |a 268B43MJ25 |2 NLM | |
700 | 1 | |a Li, Shiwei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xinxin |e verfasserin |4 aut | |
700 | 1 | |a Huang, Bo |e verfasserin |4 aut | |
700 | 1 | |a Fu, Yuhong |e verfasserin |4 aut | |
700 | 1 | |a Li, Xin |e verfasserin |4 aut | |
700 | 1 | |a Cui, Jingqiu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nutrition, metabolism, and cardiovascular diseases : NMCD |d 1997 |g 34(2024), 4 vom: 22. März, Seite 1021-1027 |w (DE-627)NLM090675177 |x 1590-3729 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2024 |g number:4 |g day:22 |g month:03 |g pages:1021-1027 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.numecd.2024.01.018 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2024 |e 4 |b 22 |c 03 |h 1021-1027 |